Le Lézard
Classified in: Health
Subjects: AWD, NPT

Liberty HealthShare CEO Recognized as 'Social Impact Hero'


CANTON, Ohio, April 5, 2024 /PRNewswire/ -- Dorsey Morrow, chief executive officer of Liberty HealthShare®, one of the country's leading Christian healthcare sharing ministries, has been recognized as a "Social Impact Hero" by Authority Magazine.

Dorsey Morrow, Liberty HealthShare CEO, Recognized as 'Social Impact Hero'

As a part of the magazine's series about "individuals and organizations making an important social impact," Morrow was featured in the April 1 issue.

"With over two decades of background in law and non-profits, Morrow's leadership is propelling Liberty into its new era, creating a movement toward a more compassionate, affordable and sustainable approach to financing health," wrote Yitzi Weiner, Authority Magazine founder and editor.

Asked by Weiner how he and Liberty HealthShare are making a significant social impact, Morrow responded: "We are challenging the status quo in the healthcare industry. We are giving the end-user the freedom to choose who they see and what they want done, as well as increasing the transparency of the entire process and cost.

"As a ministry, our members are helping each other, both physically and spiritually. They are able to engage in each other's lives and well-being, something that has become almost an anathema in today's social-media-based society. Our members want to help each other and exemplify the love exhibited in the Bible."

Weiner's full interview with Morrow can be found at: https://medium.com/authority-magazine/social-impact-heroes-why-how-dorsey-morrow-of-liberty-healthshare-is-helping-to-change-our-world-51c83724ccc0.

Liberty HealthShare offers six affordable medical cost sharing programs that are designed to fit the needs of individuals as well as different types and sizes of families. As Liberty HealthShare is not insurance, enrollment is available year-round with no requirement for special life events to qualify. For more information visit libertyhealthshare.org or call (855) 585-4237.

Liberty HealthShare is a non-profit 501(c) (3) charitable Christian medical cost-sharing ministry focused on members helping each other in times of need. The faith-based program, which facilitates healthsharing for its members, is a caring community of health-conscious individuals and families who choose to support one another and agree to the Christian values of stewardship to make healthcare affordable for all.

Liberty HealthShare is not an insurance company nor is it offered through an insurance company. Liberty HealthShare's Sharing Programs do not guarantee or promise that a member's medical bills will be paid or assigned to others for payment. Whether anyone chooses to pay a member's medical bills will be totally voluntary. As such, Liberty HealthShare's Sharing Programs should never be considered as a substitute for an insurance policy. Whether a member receives any payments for medical expenses and whether or not Liberty HealthShare continues to operate, the member is always liable for any unpaid bills.

SOURCE Liberty HealthShare


These press releases may also interest you

at 18:14
SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the Sarcoma Centers Registry https://sarctrials.org/sarcoma-centers/, a comprehensive, global resource facilitating...

at 18:08
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced with great respect and sorrow the unexpected passing last night of...

at 18:02
It takes a unique, special kind of dedication to become a nurse. For the nurses in First Nations and Inuit communities, it takes strength, resiliency, expertise, and most importantly, heart. It takes an understanding of the complex environment of...

at 17:44
On Tuesday, May 7, 2024, The Center for Discovery® (TCFD, The Center) honored Edward C. Sweeney, TCFD Board Chair, at the 24th annual Evening of Discovery Gala. The Gala was hosted by Mo Rocca, CBS Sunday Morning Correspondent, Humorist, and Creator...

at 17:30
PT217 is Phanes' first-in-class bispecific antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibodyThe clinical supply agreement will focus on evaluating PT217 in combination with atezolizumab for the...

at 17:30
Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that data from the pre-clinical pharmacokinetics & efficacy study comparing ocular tissue distribution after ocular instillation of tivozanib eye drops will be presented at the upcoming Association...



News published on and distributed by: